Signet Jewelers Ltd - Company Profile
Powered by
All the data and insights you need on Signet Jewelers Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Signet Jewelers Ltd Strategy Report
- Understand Signet Jewelers Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Signet Jewelers Ltd patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
US11332520B2 | Grant | Human antibodies and binding fragments thereof to tenascin | A61K39/00; A61P19/02; C07K16/18; C07K2317/21; C07K2317/55; C07K2317/565; C12N15/63 | May 17, 2022 |
IL282201B | Grant | Anti-tenascin c antibodies and uses thereof | A61K2039/505; A61K39/3955; A61P1/04; A61P1/16; A61P11/00; A61P11/06; A61P17/00; A61P17/02; A61P17/06; A61P17/16; A61P25/00; A61P29/00; A61P3/10; A61P35/00; A61P37/02; A61P37/06; A61P9/00; A61P9/10; C07K14/78; C07K16/18; C07K16/28; C07K2317/33; C07K2317/55; C07K2317/56; C07K2317/565; C07K2317/567; C07K2317/76; C07K2317/92; C07K2319/30; G01N2333/705; G01N2800/52; G01N2800/7095; G01N33/6893 | April 01, 2022 |
AU2017218535B2 | Grant | Human antibodies and binding fragments thereof to tenascin | A61K2039/505; A61K2039/54; A61K2039/545; A61K39/00; A61K39/3955; A61P1/00; A61P1/02; A61P1/04; A61P1/16; A61P1/18; A61P11/00; A61P11/06; A61P13/12; A61P15/00; A61P17/00; A61P17/02; A61P17/04; A61P17/14; A61P19/02; A61P19/08; A61P19/10; A61P21/04; A61P25/00; A61P25/02; A61P25/28; A61P27/02; A61P27/16; A61P29/00; A61P3/06; A61P3/10; A61P35/00; A61P35/04; A61P37/02; A61P37/06; A61P37/08; A61P5/00; A61P5/38; A61P7/04; A61P7/06; A61P9/00; A61P9/10; A61P9/14; C07K16/18; C07K2317/21; C07K2317/33; C07K2317/55; C07K2317/565; C07K2317/76; C07K2317/92; C12N15/63; G01N2333/435; G01N2800/24; G01N2800/52; G01N33/6893; Y02A50/30 | March 31, 2022 |
US20210355201A1 | Application | ANTI-TENASCIN C ANTIBODIES AND USES THEREOF | A61K2039/505; A61K39/3955; A61P1/04; A61P1/16; A61P11/00; A61P11/06; A61P17/00; A61P17/02; A61P17/06; A61P17/16; A61P25/00; A61P29/00; A61P3/10; A61P35/00; A61P37/02; A61P37/06; A61P9/00; A61P9/10; C07K14/78; C07K16/18; C07K2317/33; C07K2317/55; C07K2317/56; C07K2317/565; C07K2317/567; C07K2317/76; C07K2317/92; C07K2319/30; G01N33/6893 | November 18, 2021 |
CN113583121A | Application | ANTI-TENASCIN C ANTIBODIES AND USES THEREOF | A61K2039/505; A61K39/3955; A61P1/04; A61P1/16; A61P11/00; A61P11/06; A61P17/00; A61P17/02; A61P17/06; A61P17/16; A61P25/00; A61P29/00; A61P3/10; A61P35/00; A61P37/02; A61P37/06; A61P9/00; A61P9/10; C07K14/78; C07K16/18; C07K16/28; C07K2317/33; C07K2317/55; C07K2317/56; C07K2317/565; C07K2317/567; C07K2317/76; C07K2317/92; C07K2319/30; G01N2333/705; G01N2800/52; G01N2800/7095; G01N33/6893 | November 02, 2021 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer